Literature DB >> 8536608

Developmental expression of a candidate müllerian inhibiting substance type II receptor.

J Teixeira1, W W He, P C Shah, N Morikawa, M M Lee, E A Catlin, P L Hudson, J Wing, D T Maclaughlin, P K Donahoe.   

Abstract

We have isolated a candidate Müllerian inhibiting substance (MIS) type II receptor complementary DNA from an embryonic rat urogenital ridge library and have studied its binding to MIS, its developmental pattern of expression and tissue distribution. By in situ hybridization with a full-length riboprobe, the receptor is expressed in the mesenchymal cells surrounding the Müllerian duct at embryonic days 14, 15, and 16 and in tubular and follicular structures of the rat fetal gonads. Expression of the messenger RNA was also seen in the granules cells and seminiferous tubules of pubertal gonads. Northern analysis revealed that the MIS type II receptor messenger RNA is highly expressed in embryonic, pubertal, and adult testes and ovaries, as well as in the gravid uterus. The timing of expression in the gonads of both sexes was also analyzed by Northern analyses that showed high levels of expression at the time of Müllerian duct regression, much lower levels neonatally and prepubertally and then increased expression again with sexual maturation. The tissue and developmental specificity of expression of this receptor, which make it likely that this is the functional MIS type II receptor, can be used to advantage in therapeutic targeting strategies and to decipher the function of MIS in the gonads.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8536608     DOI: 10.1210/endo.137.1.8536608

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  36 in total

1.  Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance.

Authors:  Elizabeth J Renaud; David T MacLaughlin; Esther Oliva; Bo R Rueda; Patricia K Donahoe
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-23       Impact factor: 11.205

2.  Conditional deletion of beta-catenin mediated by Amhr2cre in mice causes female infertility.

Authors:  Jennifer A Hernandez Gifford; Mary E Hunzicker-Dunn; John H Nilson
Journal:  Biol Reprod       Date:  2009-01-28       Impact factor: 4.285

3.  Adenomatous polyposis coli (APC) is essential for maintaining the integrity of the seminiferous epithelium.

Authors:  Pradeep S Tanwar; Lihua Zhang; Jose M Teixeira
Journal:  Mol Endocrinol       Date:  2011-08-04

4.  CAR T Cells Targeting MISIIR for the Treatment of Ovarian Cancer and Other Gynecologic Malignancies.

Authors:  Alba Rodriguez-Garcia; Prannda Sharma; Mathilde Poussin; Alina C Boesteanu; Nicholas G Minutolo; Sarah B Gitto; Dalia K Omran; Matthew K Robinson; Gregory P Adams; Fiona Simpkins; Daniel J Powell
Journal:  Mol Ther       Date:  2019-12-06       Impact factor: 11.454

5.  The gene encoding anti-müllerian hormone type 2 receptor maps to mouse chromosome 15.

Authors:  T Kunieda; I Ojika; H Katoh
Journal:  Mamm Genome       Date:  1998-03       Impact factor: 2.957

6.  Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model.

Authors:  V Gupta; J L Carey; H Kawakubo; A Muzikansky; J E Green; P K Donahoe; D T MacLaughlin; S Maheswaran
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

7.  Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo.

Authors:  A E Stephen; P T Masiakos; D L Segev; J P Vacanti; P K Donahoe; D T MacLaughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

8.  Müllerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents.

Authors:  A M Trbovich; P M Sluss; V M Laurich; F H O'Neill; D T MacLaughlin; P K Donahoe; J Teixeira
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

9.  Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines.

Authors:  Henry L Chang; Rafael Pieretti-Vanmarcke; Fotini Nicolaou; Xianlin Li; Xiaolong Wei; David T MacLaughlin; Patricia K Donahoe
Journal:  Gynecol Oncol       Date:  2010-11-06       Impact factor: 5.482

10.  Induction of WNT inhibitory factor 1 expression by Müllerian inhibiting substance/antiMullerian hormone in the Müllerian duct mesenchyme is linked to Müllerian duct regression.

Authors:  Joo Hyun Park; Yoshihiro Tanaka; Nelson A Arango; Lihua Zhang; L Andrew Benedict; Mi In Roh; Patricia K Donahoe; Jose M Teixeira
Journal:  Dev Biol       Date:  2013-12-19       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.